Geoepidemiology of primary sclerosing cholangitis: A critical review

Journal of Autoimmunity

Volumn 46, Issue , 2013, Pages 35-40

  Tanaka, Atsushi ^a   Takikawa, Hajime ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Epidemiology; IgG4 sclerosing cholangitis; Incidence; Prevalence

Indexed keywords

IMMUNOGLOBULIN G4;

AGE DISTRIBUTION; CLINICAL FEATURE; COHORT ANALYSIS; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTERITIS; EUROPE; GENETIC VARIABILITY; HUMAN; INCIDENCE; JAPAN; NORTH AMERICA; PANCREAS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; REVIEW; SPAIN;

AIP; AUTOIMMUNE PANCREATITIS; CCA; CHOLANGIOCARCINOMA; EPIDEMIOLOGY; GG4-RELATED SCLEROSING CHOLANGITIS; IBD; IGG4-SCI; IGG4-SCLEROSING CHOLANGITIS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; PSC; UC; ULCERATIVE COLITIS;

CHOLANGITIS, SCLEROSING; DIAGNOSIS, DIFFERENTIAL; EUROPE; HUMANS; INCIDENCE; JAPAN; NORTH AMERICA; PREVALENCE;

EID: 84886280206     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2013.07.005     Document Type: Review

References (54)

1. Hirschfield G.M., Karlsen T.H., Lindor K.D., Adams D.H. Primary sclerosing cholangitis. Lancet 2013, [Epub ahead of print].
2. Karlsen T.H., Boberg K.M. Update on primary sclerosing cholangitis. JHepatol 2013, [Epub ahead of print].
3. Molodecky N.A., Kareemi H., Parab R., Barkema H.W., Quan H., Myers R.P., et al. Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology 2011, 53:1590-1599.
4. Bambha K., Kim W.R., Talwalkar J., Torgerson H., Benson J.T., Therneau T.M., et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003, 125:1364-1369.
5. Berdal J.E., Ebbesen J., Rydning A. Incidence and prevalence of autoimmune liver diseases. Tidsskr Nor Laegeforen 1998, 118:4517-4519.
6. Boberg K.M., Aadland E., Jahnsen J., Raknerud N., Stiris M., Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998, 33:99-103.
7. Boonstra K., Weersma R.K., van Erpecum K.J., Rauws E.A., Spanier B.W., Poen A.C., et al. Population-based epidemiology, malignancy risk and outcome of primary sclerosing cholangitis. Hepatology 2013, [Epub ahead of print].
8. Card T.R., Solaymani-Dodaran M., West J. Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study. JHepatol 2008, 48:939-944.
9. Escorsell A., Pares A., Rodes J., Solis-Herruzo J.A., Miras M., de la Morena E. Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. JHepatol 1994, 21:787-791.
10. Kaplan G., Laupland K., Butzner D., Urbanski S., Lee S. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol 2007, 102:1042-1049.
11. Kingham J.G., Kochar N., Gravenor M.B. Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom. Gastroenterology 2004, 126:1929-1930.
12. Lindkvist B., Benito de Valle M., Gullberg B., Bjornsson E. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology 2010, 52:571-577.
13. Takikawa H., Manabe T. Primary sclerosing cholangitis in Japan - analysis of 192 cases. JGastroenterol 1997, 32:134-137.
14. Takikawa H., Takamori Y., Tanaka A., Kurihara H., Nakanuma Y. Analysis of 388 cases of primary sclerosing cholangitis in Japan; presence of a subgroup without pancreatic involvement in older patients. Hepatol Res 2004, 29:153-159.
15. Hamano H., Kawa S., Uehara T., Ochi Y., Takayama M., Komatsu K., et al. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis?. Gastrointest Endosc 2005, 62:152-157.
16. Uehara T., Hamano H., Kawa S., Sano K., Honda T., Ota H. Distinct clinicopathological entity 'autoimmune pancreatitis-associated sclerosing cholangitis'. Pathol Int 2005, 55:405-411.
17. Zen Y., Harada K., Sasaki M., Sato Y., Tsuneyama K., Haratake J., et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?. Am J Surg Pathol 2004, 28:1193-1203.
18. Hamano H., Umemura T., Uehara T., Kawa S., Kiyosawa K. IgG4-related sclerosing cholangitis should be included as an exclusion criterion for the diagnosis of primary sclerosing cholangitis. Am J Gastroenterol 2007, 102:691-692.
19. Ohara H., Okazaki K., Tsubouchi H., Inui K., Kawa S., Kamisawa T., et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. JHepatobiliary Pancreat Sci 2012, 19:536-542.
20. Tanaka A, Tazuma S, Okazaki K, Tsubouchi H, Inui K, Takikawa H. A nationwide survey of primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. Submitted for publication.
21. Tanaka A. The epidemiological study of PSC in Japan. Health Labour Sciences Research Grant from Research on Measures for Intractable Diseases, the intractable hepato-biliary disease study group in Japan 2008, [in Japanese].
22. Lindor K., LaRusso N. Primary sclerosing cholangitis. Schiff's disease of the liver 2007, 673-684. Lippincott Williams & Wilkins, Philadelphia. 10th ed. E. Schiff (Ed.).
23. Broome U., Olsson R., Loof L., Bodemar G., Hultcrantz R., Danielsson A., et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996, 38:610-615.
24. Farrant J., Hayllar K., Wilkinson M., Karani J., Portmann B., Westaby D., et al. Natural history and prognostic variables in primary sclerosing cholangitis. Ganstroenterology 1991, 100:1710-1717.
25. Schrumpf E., Abdelnoor M., Fausa O., Elgjo K., Jenssen E., Kolmannskog F. Risk factors in primary sclerosing cholangitis. JHepatol 1994, 21:1061-1066.
26. Wiesner R.H., Grambsch P.M., Dickson E.R., Ludwig J., MacCarty R.L., Hunter E.B., et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989, 10:430-436.
27. Ang T.L., Fock K.M., Ng T.M., Teo E.K., Chua T.S., Tan J.Y. Clinical profile of primary sclerosing cholangitis in Singapore. JGastroenterol Hepatol 2002, 17:908-913.
28. Ye B.D., Yang S.K., Boo S.J., Cho Y.K., Yang D.H., Yoon S.M., et al. Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea. Inflamm Bowel Dis 2011, 17:1901-1906.
29. Hamano H., Kawa S., Horiuchi A., Unno H., Furuya N., Akamatsu T., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. NEngl J Med 2001, 344:732-738.
30. Erkelens G., Vleggaar F., Lesterhuis W., van Buuren H., van der Werf S. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet 1999, 354:43-44.
31. Horiuchi A., Kawa S., Hamano H., Ochi Y., Kiyosawa K. Sclerosing pancreato-cholangitis responsive to corticosteroid therapy: report of 2 case reports and review. Gastrointest Endosc 2001, 53:518-522.
32. Kamisawa T., Tabata T. IgG4-related sclerosing cholangitis. Ann Hepatol 2011, 10:552-555.
33. Ghazale A., Chari S.T., Zhang L., Smyrk T.C., Takahashi N., Levy M.J., et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008, 134:706-715.
34. Mendes F., Jorgensen R., Keach J., Katzmann J., Smyrk T., Donlinger J., et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006, 101:2070-2075.
35. Nakazawa T., Naitoh I., Hayashi K., Okumura F., Miyabe K., Yoshida M., et al. Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification. JGastroenterol 2012, 47:79-87.
36. Nakazawa T., Ohara H., Sano H., Ando T., Aoki S., Kobayashi S., et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas 2005, 30:20-25.
37. Nakazawa T., Ohara H., Sano H., Ando T., Joh T. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas 2006, 32:229.
38. Kalaitzakis E., Levy M., Kamisawa T., Johnson G.J., Baron T.H., Topazian M.D., et al. Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma. Clin Gastroenterol Hepatol 2011, 9:800-803. e2.
39. Shoenfeld Y., Tincani A., Gershwin M.E. Sex gender and autoimmunity. JAutoimmun 2012, 38:J71-J73.
40. Rogers M.A., Levine D.A., Blumberg N., Fisher G.G., Kabeto M., Langa K.M. Antigenic challenge in the etiology of autoimmune disease in women. JAutoimmun 2012, 38:J97-J102.
41. Quintero O.L., Amador-Patarroyo M.J., Montoya-Ortiz G., Rojas-Villarraga A., Anaya J.M. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. JAutoimmun 2012, 38:J109-J119.
42. Dillon S.P., Kurien B.T., Li S., Bruner G.R., Kaufman K.M., Harley J.B., et al. Sex chromosome aneuploidies among men with systemic lupus erythematosus. JAutoimmun 2012, 38:J129-J134.
43. Menon R., Di Dario M., Cordiglieri C., Musio S., La Mantia L., Milanese C., et al. Gender-based blood transcriptomes and interactomes in multiple sclerosis: involvement of SP1 dependent gene transcription. JAutoimmun 2012, 38:J144-J155.
44. Bogdanos D.P., Smyk D.S., Rigopoulou E.I., Mytilinaiou M.G., Heneghan M.A., Selmi C., et al. Twin studies in autoimmune disease: genetics, gender and environment. JAutoimmun 2012, 38:J156-J169.
45. Pollard K.M. Gender differences in autoimmunity associated with exposure to environmental factors. JAutoimmun 2012, 38:J177-J186.
46. Borchers A.T., Gershwin M.E. Sociological differences between women and men: implications for autoimmunity. Autoimmun Rev 2012, 11:A413-A421.
47. Selmi C., Brunetta E., Raimondo M.G., Meroni P.L. The X chromosome and the sex ratio of autoimmunity. Autoimmun Rev 2012, 11:A531-A537.
48. Pan Z., Chang C. Gender and the regulation of longevity: implications for autoimmunity. Autoimmun Rev 2012, 11:A393-A403.
49. Lee T.P., Chiang B.L. Sex differences in spontaneous versus induced animal models of autoimmunity. Autoimmun Rev 2012, 11:A422-A429.
50. Gatto M., Iaccarino L., Canova M., Zen M., Nalotto L., Ramonda R., et al. Pregnancy and vasculitis: a systematic review of the literature. Autoimmun Rev 2012, 11:A447-A459.
51. Bianchi I., Lleo A., Gershwin M.E., Invernizzi P. The X chromosome and immune associated genes. JAutoimmun 2012, 38:J187-J192.
52. Amur S., Parekh A., Mummaneni P. Sex differences and genomics in autoimmune diseases. JAutoimmun 2012, 38:J254-J265.
53. Pennell L.M., Galligan C.L., Fish E.N. Sex affects immunity. JAutoimmun 2012, 38:J282-J291.
54. Friedrich K., Rupp C., Hov J.R., Steinebrunner N., Weiss K.H., Stiehl A., et al. Afrequent PNPLA3 variant is a sex specific disease modifier in PSC patients with bile duct stenosis. PloS One 2013, 8:e58734.